The UK’s system for pricing drugs is to move from one based on controlling profits to a value-based approach. The switch has implications for other countries in Europe.
Venture capitalists are on a roll: in the past week two more firms confirmed the closing of significant new funds, to add to five others announced this year.
The open-source software company Red Hat is opening a centre for support and R&D in Serbia, building on a project initiated in 2005 by Belgrade University to create an incubator for new technologies.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.